A data frame with 2139 observations on the following 27 variables:

pidnum

    patient's ID number
age

    age in years at baseline
wtkg

    weight in kg at baseline
hemo

    hemophilia (0=no, 1=yes)
homo

    homosexual activity (0=no, 1=yes)
drugs

    history of intravenous drug use (0=no, 1=yes)
karnof

    Karnofsky score (on a scale of 0-100)
oprior

    non-zidovudine antiretroviral therapy prior to initiation of study treatment (0=no, 1=yes)
z30

    zidovudine use in the 30 days prior to treatment initiation (0=no, 1=yes)
zprior

    zidovudine use prior to treatment initiation (0=no, 1=yes)
preanti

    number of days of previously received antiretroviral therapy
race

    race (0=white, 1=non-white)
gender

    gender (0=female, 1=male)
str2

    antiretroviral history (0=naive, 1=experienced)
strat

    antiretroviral history stratification (1='antiretroviral naive', 2='> 1 but â‰¤q 52 weeks of prior antiretroviral therapy', 3='> 52 weeks')
symptom

    symptomatic indicator (0=asymptomatic, 1=symptomatic)
treat

    treatment indicator (0=zidovudine only, 1=other therapies)
offtrt

    indicator of off-treatment before 96\pm5 weeks (0=no,1=yes)
cd40

    CD4 T cell count at baseline
cd420

    CD4 T cell count at 20\pm5 weeks
cd496

    CD4 T cell count at 96\pm5 weeks (=NA if missing)
r

    missing CD4 T cell count at 96\pm5 weeks (0=missing, 1=observed)
cd80

    CD8 T cell count at baseline
cd820

    CD8 T cell count at 20\pm5 weeks
cens

    indicator of observing the event in days
days

    number of days until the first occurrence of: (i) a decline in CD4 T cell count of at least 50 (ii) an event indicating progression to AIDS, or (iii) death.
arms

    treatment arm (0=zidovudine, 1=zidovudine and didanosine, 2=zidovudine and zalcitabine, 3=didanosine).

More informations here: https://rdrr.io/cran/speff2trial/man/ACTG175.html
